Bridgefront Capital, LLC Agilent Technologies, Inc. Transaction History

Bridgefront Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$129.63 - $154.64 $117,315 - $139,949	905 Added 53.24%	2,605 $337,000
Q1 2024 May 15, 2024	SELL	$128.12 - $149.31 $15,630 - $18,215	-122 Reduced 6.7%	1,700 $247,000
Q4 2023 Feb 14, 2024	SELL	$101.17 - $139.82 $591,237 - $817,108	-5,844 Reduced 76.23%	1,822 $253,000
Q3 2023 Nov 14, 2023	BUY	$109.73 - $128.47 $431,568 - $505,272	3,933 Added 105.36%	7,666 $857,000
Q2 2023 Aug 14, 2023	SELL	$114.69 - $141.28 $59,638 - $73,465	-520 Reduced 12.23%	3,733 $448,000
Q1 2023 May 15, 2023	SELL	$131.13 - $159.06 $188,302 - $228,410	-1,436 Reduced 25.24%	4,253 $588,000
Q4 2022 Feb 14, 2023	BUY	$125.64 - $157.68 $714,765 - $897,041	5,689 New	5,689 $851,000
Q1 2021 May 17, 2021	SELL	$114.99 - $130.12 $1.35 Million - $1.53 Million	-11,759 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$100.01 - $119.3 $1.18 Million - $1.4 Million	11,759 New	11,759 $1.39 Million

1,149

252M

729K

970K

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $40.9B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.